Advances in Hematological Malignancies
Recent years have witnessed remarkable advancements in the domain of hematological malignancies. Novel therapies such as targeted agents, immunotherapies, and therapy are altering the outlook for patients with blood cancers. Ongoing investigations continue to explore these innovative techniques, offering promise for more effective treatment options